CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children

BMC Pediatrics

Volumn 13, Issue 1, 2013, Pages

  Fitrolaki, Diana Michaela ^a   Dimitriou, Helen ^b   Kalmanti, Maria ^b   Briassoulis, George ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

CD11b; CD64; Glucose; Lipoproteins; Metabolic pattern; Neutrophils; Sepsis; Traumatic brain injury

Indexed keywords

C REACTIVE PROTEIN; CD11B ANTIGEN; CD64 ANTIGEN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROCALCITONIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; INFANT; LENGTH OF STAY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLISM; MONOCYTE; NEUTROPHIL; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAUMATIC BRAIN INJURY;

ACUTE DISEASE; ADOLESCENT; ANTIGENS, CD11B; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BRAIN INJURIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; LIPOPROTEINS; LYMPHOCYTES; MALE; MONOCYTES; NEUTROPHILS; PROSPECTIVE STUDIES; RECEPTORS, IGG; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; STRESS, PHYSIOLOGICAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRIGLYCERIDES;

EID: 84874398306     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-13-31     Document Type: Article

References (49)

1. Dhar A, Castillo L. Insulin resistance in critical illness. Curr Opin Pediatr 2011, 23(3):269-274. 10.1097/MOP.0b013e3283464b3e, 21508840.
2. Ruchaud-Sparagano MH, Stocks SC, Turley H, Dransfield I. Activation of neutrophil function via CD66: differential effects upon beta 2 integrin mediated adhesion. Br J Haematol 1997, 98:612-620. 10.1046/j.1365-2141.1997.2523070.x, 9332316.
3. Davis BH. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn 2005, 5:193-207. 10.1586/14737159.5.2.193, 15833049.
4. Herra CM, Keane TC, Whelan A. Increased expression of Fc gamma receptors on neutrophils and monocytes may reflect ongoing bacterial infection. J Med Microbiol 1996, 44:135-140. 10.1099/00222615-44-2-135, 8642575.
5. Groselj-Grenc M, Ihan A, Derganc M. Neutrophil and Monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm 2008, 2008:202646. 2442385, 18604302.
6. Cardelli P, Ferraironi M, Amodeo R, Tabacco F, De Blasi RA, Nicoletti M, Sessa R, Petrucca A, Costante A, Cipriani P. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 2008, 21:43-49.
7. Davis BH, Olsen SH, Ahmad E, Bigelow NC. Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients. Arch Pathol Lab Med 2006, 130:654-661.
8. Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med 2009, 35:1950-1958. 10.1007/s00134-009-1637-7, 19756501.
9. Russwurm S, Vickers J, Meier-Hellmann A, Spangenberg P, Bredle D, Reinhart K, Losche W. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 2002, 17:263-268. 10.1097/00024382-200204000-00004, 11954824.
10. Weinschenk NP, Farina A, Bianchi DW. Premature infants respond to early-onset and late-onset sepsis with leukocyte activation. J Pediatr 2000, 137:345-350. 10.1067/mpd.2000.107846, 10969258.
11. Nakae H, Endo S, Inada K, Takakuwa T, Kasai T. Changes in adhesion molecule levels in sepsis. Res Commun Mol Pathol Pharmacol 1996, 91:329-338.
12. Briassoulis G, Venkataraman S, Thompson A. Cytokines and metabolic patterns in pediatric patients with critical illness. Clin Dev Immunol 2010, 2010:354047. 2871553, 20490277.
13. Wolfe RR, Martini WZ. Changes in intermediary metabolism in severe surgical illness. World J Surg 2000, 24:639-647. 10.1007/s002689910105, 10773115.
14. Hohl A, Gullo JD, Silva CC, Bertotti MM, Felisberto F, Nunes JC, de Souza B, Petronilho F, Soares FM, Prediger RD, Dal-Pizzol F, Linhares MN, Walz R. Plasma levels of oxidative stress biomarkers and hospital mortality in severe head injury: a multivariate analysis. J Crit Care 2011, Epub ahead of print.
15. Arun P, Ariyannur PS, Moffett JR, Xing G, Hamilton K, Grunberg NE, Ives JA, Namboodiri AM. Metabolic acetate therapy for the treatment of traumatic brain injury. J Neurotrauma 2010, 27(1):293-298. 10.1089/neu.2009.0994, 2824219, 19803785.
16. Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986, 32(1 Pt 1):142-145.
17. Barlage S, Gnewuch C, Liebisch G, Wolf Z, Audebert FX, Glück T, Fröhlich D, Krämer BK, Rothe G, Schmitz G. Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to Monocyte and platelet activation. Intensive Care Med 2009, 35(11):1877-1885. 10.1007/s00134-009-1609-y, 19669126.
18. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, Barie PS, Rubin AL. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med 2001, 29(8):1563-1568. 10.1097/00003246-200108000-00011, 11505128.
19. Hubsch AP, Casas AT, Doran JE. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models. J Lab Clin Med 1995, 126(6):548-558.
20. Pajkrt D, Doran JE, Koster F, Lerch PG, Arnet B, van der Poll T, ten Cate JW, van Deventer SJ. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 1996, 184(5):1601-1608. 10.1084/jem.184.5.1601, 2192853, 8920850.
21. Briassoulis G, Filippou O, Kanariou M, Hatzis T. Comparative effects of early randomized immune or non-immune-enhancing enteral nutrition on cytokine production in children with septic shock. Intensive Care Med 2005, 31(6):851-858. 10.1007/s00134-005-2631-3, 15834703.
22. Briassoulis G, Filippou O, Kanariou M, Papassotiriou I, Hatzis T. Temporal nutritional and inflammatory changes in children with severe head injury fed a regular or an immune-enhancing diet: a randomized, controlled trial. Pediatr Crit Care Med 2006, 7(1):56-62. 10.1097/01.PCC.0000192339.44871.26, 16395076.
23. Li L, Roumeliotis N, Sawamura T, Renier G. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ Res 2004, 95(9):877-883. 10.1161/01.RES.0000147309.54227.42, 15472120.
24. Beekman JM, van der Linden JA, van de Winkel JG, Leusen JH. FcgammaRI (CD64) resides constitutively in lipid rafts. Immunol Lett 2008, 116(2):149-155. 10.1016/j.imlet.2007.12.003, 18207250.
25. Wolf Z, Orsó E, Werner T, Klünemann HH, Schmitz G. Monocyte cholesterol homeostasis correlates with the presence of detergent resistant membrane microdomains. Cytometry A 2007, 71(7):486-494.
26. Lopes-Virella MF, Binzafar N, Rackley S, Takei A, La Via M, Virella G. The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor. Atherosclerosis 1997, 135(2):161-170. 10.1016/S0021-9150(97)00157-3, 9430365.
27. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated pediatric risk of mortality score. Crit Care Med 1996, 24(5):743-752. 10.1097/00003246-199605000-00004, 8706448.
28. Keene AR, Cullen DJ. Therapeutic intervention scoring system: update. Crit Care Med 1983, 11:1-3. 10.1097/00003246-198301000-00001, 6848305.
29. Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, Lacroix J, Leclerc F. Validation of the paediatric logistic organ dysfuntion (PELOD) score: prospective, observational, multicentre study. Lancet 2003, 362:192-197. 10.1016/S0140-6736(03)13908-6, 12885479.
30. Goldstein B, Giroir B, Randolph A. International consensus conference on pediatric sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6:2-8. 10.1097/01.PCC.0000149131.72248.E6, 15636651.
31. Qureshi SS, Lewis SM, Gant VA, Treacher D, Davis BH, Brown KA. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin Exp Immunol 2001, 125:258-265. 10.1046/j.1365-2249.2001.01596.x, 1906134, 11529918.
32. Streimish I, Bizzarro M, Northrup V, Wang C, Renna S, Koval N, Li FY, Ehrenkranz R, Rinder HM, Bhandari V. Neutrophil cd64 as a diagnostic marker in neonatal sepsis. Pediatr Infect Dis J 2012, 31:777-781. 10.1097/INF.0b013e318256fb07, 22481422.
33. Genel F, Atlihan F, Gulez N, Kazanci E, Vergin C, Terek DT, Yurdun OC. Evaluation of adhesion molecules CD64, CD11b and CD62L in neutrophils and monocytes of peripheral blood for early diagnosis of neonatal infection. World J Pediatr 2012, 8:72-75. 10.1007/s12519-011-0304-6, 21874613.
34. Livaditi O, Kotanidou A, Psarra A, Dimopoulou I, Sotiropoulou C, Augustatou K, Papasteriades C, Armaganidis A, Roussos C, Orfanos SE, Douzinas EE. Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine 2006, 36:283-290. 10.1016/j.cyto.2007.02.007, 17368039.
35. Hsu KH, Chan MC, Wang JM, Lin LY, Wu CL. Comparison of Fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients. Respirology 2011, 16:152-160. 10.1111/j.1440-1843.2010.01876.x, 20946336.
36. Brunialti MK, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, Salomao R. TLR2, TLR4, CD14, CD11B, And CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 2006, 25:351-357. 10.1097/01.shk.0000217815.57727.29, 16670636.
37. Gros A, Roussel M, Sauvadet E, Gacouin A, Marqué S, Chimot L, Lavoué S, Camus C, Fest T, Le Tulzo Y. The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients. Intensive Care Med 2012, 38(3):445-452. 10.1007/s00134-012-2483-6, 22310872.
38. Lüthold S, Berneis K, Bady P, Müller B. Effects of infectious disease on plasma lipids and their diagnostic significance in critical illness. Eur J Clin Invest 2007, 37(7):573-579. 10.1111/j.1365-2362.2007.01826.x, 17576209.
39. Gruber M, Christ-Crain M, Stolz D, Keller U, Müller C, Bingisser R, Tamm M, Mueller B, Schuetz P. Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study. Swiss Med Wkly 2009, 139(11-12):166-172.
40. Kumaraswamy SB, Linder A, Akesson P, Dahlbäck B. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit Care 2012, 16(2):R60. Epub ahead of print, 10.1186/cc11305, 22512779.
41. van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003, 31(5):1359-1366. 10.1097/01.CCM.0000059724.08290.51, 12771603.
42. Kosuge M, Kimura K, Ishikawa T, Shimizu T, Sugano T, Sumita S, Hibi K, Takamura T, Toda N, Kanna M, Tsukahara K, Okuda J, Tahara Y, Nozawa N, Furukawa E, Umemura S. Different clinical and coronary angiographic findings according to ratios of total cholesterol to high-density lipoprotein cholesterol during the acute phase of myocardial infarction. J Cardiol 2004, 43(6):251-258.
43. Zhang L, Qiao Q, Tuomilehto J, Hammar N, Ruotolo G, Stehouwer CD, Heine RJ, Eliasson M, Zethelius B, DECODE Study Group The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE study. Atherosclerosis 2009, 206(1):298-302. 10.1016/j.atherosclerosis.2008.12.043, 19303072, DECODE Study Group.
44. Harris HW, Johnson JA, Wigmore SJ. Endogenous lipoproteins impact the response to endotoxin in humans. Crit Care Med 2002, 30(1):23-31. 10.1097/00003246-200201000-00004, 11902267.
45. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004, 89(1):219-226. 10.1210/jc.2003-030760, 14715853.
46. Yang SY, Zhang S, Wang ML. Clinical significance of admission hyperglycemia and factors related to it in patients with acute severe head injury. Surg Neurol 1995, 44:373-377. 10.1016/0090-3019(96)80243-6, 8553258.
47. Dunham CM, Chirichella TJ. Attenuated hypocholesterolemia following severe trauma signals risk for late ventilator-associated pneumonia, ventilator dependency, and death: a retrospective study of consecutive patients. Lipids Health Dis 2011, 10:42. 10.1186/1476-511X-10-42, 3058028, 21371328.
48. Verhoeven JJ, den Brinker M, Hokken-Koelega AC, Hazelzet JA, ten Joos KF. Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study. Crit Care 2011, 15(1):R44. 10.1186/cc10006, 3221973, 21276273.
49. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011, 34:392-397. 10.2337/dc10-1676, 3024355, 21270197.